Melbourne, Victoria, Australia – 25 July 2017
Trajan Scientific and Medical (Trajan) has announced its investment in award-winning PR consultancy LBPR, based on an alignment of company values and a shared vision to impact human wellbeing around the world.
LBPR will now have a presence in all major cities along the Eastern Seaboard of Australia, and internationally in the UK, Europe, US, and Asia.
Stephen Tomisich, CEO of the Trajan group, comments: “Core to Trajan’s vision is the personalization of science - to see people, the public, empowered through personalized scientific information, to care for their own wellbeing. LBPR brings to the Trajan group the public communications skills needed to deliver the right messages, the valuable content, that is required to achieve that vision.
He continues: “However, our alignment with Lisa Burling and LBPR is about more than that. LBPR’s award-winning track record speaks for itself and we admire the terrific campaigns and initiatives completed by Lisa and her team; from supporting healthcare and wellbeing-related clients through to helping younger people pursue careers in PR via their impressive global first student consultancy initiative, Catalyst.”
Lisa Burling, Founder and Managing Director of LBPR says: “With over 20 years of PR experience, most of it in the UK and Europe, the next step for me personally was always to take LBPR globally - but to do so in an innovative and thoughtfully disruptive way.
“We envisage a future where “Public” relations will be more about “People” relations – personalized, inter-connected messaging and sharing that helps individuals and organizations truly achieve their business goals through the power of human connection.
Trajan and LBPR’s partnership bucks the trend of traditional funding models, which see businesses in the growth phase court and choose investors based solely on financial value, and often from a similar market.
Lisa adds: “The decision to partner with Trajan marks the start of a journey that will see us work together to transform the way companies communicate with their audiences. To truly impact human wellbeing, we need to heed the learnings of today, but look firmly to the future and the enormous opportunities ahead. I know Stephen joins me in recognizing this is an exciting time for Trajan, LBPR and the broader industries in which we operate.”
Photo: Stephen Tomisich, CEO, Trajan Scientific and Medical, and Lisa Burling, Managing Director, LBPR.
Press release [PDF]
Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1244 403 100
Lisa Burling, LBPR
Tel: +61 (0) 429 976 718